Cemiplimab, a Human PD-1 Monoclonal Antibody, Versus Chemotherapy in First-Line Treatment of Advanced NSCLC with PD-L1 >= 50%

Simple item page
dc.contributor.authorSezer, A.
dc.contributor.authorGogishvili, M.
dc.contributor.authorBentsion, D.
dc.contributor.authorKilickap, S.
dc.contributor.authorLowczak, A.
dc.contributor.authorGumus, M.
dc.contributor.authorGladkow, O.
dc.contributor.authorClingan, P.
dc.contributor.authorSriuranpong, V.
dc.contributor.authorRizvi, N.
dc.contributor.authorLee, S.
dc.contributor.authorLi, S.
dc.contributor.authorSnodgrass, P.
dc.contributor.authorNavarro, M.
dc.contributor.authorLowy, I.
dc.contributor.authorRietschel, P.
dc.date.accessioned2020-10-20T10:38:41Z
dc.date.available2020-10-20T10:38:41Z
dc.date.issued2019
dc.identifier.endpageS638en_US
dc.identifier.issn1556-0864en_US
dc.identifier.issue10en_US
dc.identifier.startpageS638en_US
dc.identifier.urihttp://hdl.handle.net/11727/4938
dc.identifier.volume14en_US
dc.identifier.wos000492162203260en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.jtho.2019.08.1345en_US
dc.relation.journalJOURNAL OF THORACIC ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectnon-small-cell lung canceren_US
dc.subjectanti-PD-1en_US
dc.subjectcemiplimaben_US
dc.titleCemiplimab, a Human PD-1 Monoclonal Antibody, Versus Chemotherapy in First-Line Treatment of Advanced NSCLC with PD-L1 >= 50%en_US
dc.typeConference Objecten_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
PIIS1556086419320283.pdf
Size:
165.96 KB
Format:
Adobe Portable Document Format
Description:
Download

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Tıp Fakültesi / Faculty of Medicine
Wos Açık Erişimli Yayınlar
Wos İndeksli Yayınlar Koleksiyonu